Potential salicylamide antiplaque agents: in vitro antibacterial activity against Actinomyces viscosus
- 30 September 1981
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 24 (10) , 1245-1249
- https://doi.org/10.1021/jm00142a023
Abstract
A series of 55 salicylamides, including 3,5-dibromo-, 5-n-alkyl- and 5-n-acylsalicyloyl derivatives of various anilines, heterocyclic amines, benzylamines and alkylamines, was synthesized and evaluated for in vitro antiantibacterial activity against A. viscosus, an adherent oral microorganism implicated in periodontal disease. The in vitro minimum inhibitory concentrations of 15 4''-bromosalicylanilides correlated (r = 0.92) with estimated log D values. Several nonhalogenated salicylanilides, such as 5-n-hexyl- and 5-n-decanoyl-4''-nitrosalicylanilide, exhibit higher levels of in vitro antibacterial activity against a number of Actinomycetes than did tribomsalan or fluorophene.This publication has 6 references indexed in Scilit:
- Alkyl‐bisbiguanides as in vitro inhibitors of bacterial growth and dental plaque formationJournal of Periodontal Research, 1979
- The in vitro inhibition of microbial growth and plaque formation by surfactant drugsJournal of Periodontal Research, 1978
- In vitro antiplaque properties of a series of alkyl bis(biguanides)Journal of Medicinal Chemistry, 1978
- Comparison of Antiplaque Agents Using an In Vitro Assay Reflecting Oral ConditionsJournal of Dental Research, 1977
- Use of distribution coefficients in quantitative structure-activity relationsJournal of Medicinal Chemistry, 1977
- Substituted Salicylanilides IIIJournal of Pharmaceutical Sciences, 1963